transplant rejection Oncocyte Updates Plans for Chronix Transplant Tech; Will Develop and Market Kits in Europe Premium The move opens the first non-oncology application for Oncocyte, which acquired the relevant cell-free DNA technology in its merger with Chronix this April. Natera Q1 Revenues Grow 62 Percent The company reported $152.3 million in total revenues for the quarter and said the number of tests it processed rose 48 percent from the prior-year quarter. CareDx Q1 Revenues up 76 Percent The company reported $67.4 million in total revenues for the quarter and said testing service revenues rose 89 percent year over year. NY State Department of Health Approves Eurofins Viracor Transplant Rejection Tests The Viracor TRAC donor-derived cell-free DNA test and TruGraf blood gene expression test both assess rejection status in kidney transplant recipients. NephroSant Readies Launch of Kidney Transplant Rejection Assay Premium Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications. Mar 17, 2021 CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular Mar 16, 2021 NephroSant Raises $16M in Series A Funding Round Feb 26, 2021 GenDx HLA Genotyping Products Receives Health Canada IVD Approval Feb 25, 2021 CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring Premium Feb 24, 2021 CareDx Q4 Revenues Up 64 Percent Feb 8, 2021 Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test Feb 2, 2021 Devyser Diagnostics Raises $15.4M Through Private Placement Jan 27, 2021 Devyser Eyes Early Detection of Transplant Rejection With DNA Sequencing Tests Premium Jan 27, 2021 Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy Premium Jan 19, 2021 Devyser Receives €750K Grant to Build Sequencing Assay for Early Detection of Transplant Rejection Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 7, 2021 CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Oct 29, 2020 CareDx Q3 Revenues Up 58 Percent Oct 7, 2020 CareDx Preliminary Q3 Revenues Up 57 Percent Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Sep 17, 2020 SVB Leerink Initiates Coverage of Natera With Outperform Rating Aug 5, 2020 NeuMoDx Molecular Receives CE Mark for Quantitative BK Viral Assay Aug 4, 2020 CareDx Q2 Revenues Up 33 Percent Jun 26, 2020 BTIG Initiates Coverage of CareDx With Buy Rating Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.